Cargando…
CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients
The purpose of this study was to determine the prognostic significance of a high pretreatment serum CYFRA 21-1 level (a cytokeratin 19 fragment) adjusted for the effects of well-known co-variables in non-small-cell lung cancer (NSCLC). This meta-analysis based on individual updated data gathered com...
Autores principales: | Pujol, J-L, Molinier, O, Ebert, W, Daurès, J-P, Barlesi, F, Buccheri, G, Paesmans, M, Quoix, E, Moro-Sibilot, D, Szturmowicz, M, Bréchot, J-M, Muley, T, Grenier, J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409493/ https://www.ncbi.nlm.nih.gov/pubmed/15150567 http://dx.doi.org/10.1038/sj.bjc.6601851 |
Ejemplares similares
-
Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis
por: Boher, J-M, et al.
Publicado: (1999) -
Development and Validation of a Simplified Prognostic Score in SCLC
por: Negre, Elodie, et al.
Publicado: (2020) -
CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy
por: Barlési, F, et al.
Publicado: (2005) -
Preoperative CYFRA 21-1 level as a prognostic indicator in resected primary squamous cell lung cancer.
por: Niklinski, J., et al.
Publicado: (1996) -
Evaluation of serum cyfra21 in patients with pleural effusion
por: Azimi, Q, et al.
Publicado: (2012)